Dow Jones

39,671.04

-0.51%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Entellus Medical, Inc. (delisted) (ENTL)
Entellus Medical, Inc. (delisted) (ENTL) Noticias

ENTL

ENTELLUS MEDICAL INC (ENTL)

Entellus Medical, Inc. (delisted)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ENTL

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/02/2019	16:30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/06/2018	15:30	GlobeNewswire Inc.	Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
19/06/2018	07:00	GlobeNewswire Inc.	Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with...	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
31/05/2018	07:00	GlobeNewswire Inc.	Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATE...	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
12/03/2018	16:18	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
08/03/2018	15:27	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
07/03/2018	05:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
01/03/2018	15:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	14:50	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	12:37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	12:18	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	08:16	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	07:55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
15/02/2018	16:31	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
24/01/2018	05:11	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
08/01/2018	05:13	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
04/01/2018	08:02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
18/12/2017	15:56	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
08/12/2017	08:30	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entellus Medical, Inc.	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
07/12/2017	08:15	Dow Jones News	Stryker to Buy Entellus Medical For $662 Million	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
07/12/2017	07:15	GlobeNewswire Inc.	Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Shar...	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
14/11/2017	15:05	GlobeNewswire Inc.	Entellus Medical to Participate in Upcoming Investor Conferences	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
13/11/2017	04:30	GlobeNewswire Inc.	Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
03/11/2017	15:06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
01/11/2017	15:05	GlobeNewswire Inc.	Entellus Medical Announces Third Quarter 2017 Financial Results	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
30/10/2017	07:30	GlobeNewswire Inc.	Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
18/10/2017	15:05	GlobeNewswire Inc.	Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
04/10/2017	16:30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
25/09/2017	15:43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
25/09/2017	15:31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)